Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
halothane | Inhalation | N/A | |
isoflurane | Inhalation | N/A | |
nitrous oxide | Inhalation | N/A | |
oxygen | Inhalation (medicine gas) | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
thiopental | Powder for injection | 1 g |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bupivacaine | Injection | 0.25% (hydrochloride) in vial | |
bupivacaine | Injection | 0.5% (hydrochloride) in vial | |
lidocaine | Injection | 2% (hydrochloride) in vial | |
lidocaine | Injection | 5% (chlorhydrate) | |
lidocaine + epinephrine (adrenaline) | Solution for injection | 2% 1:80.000 |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
epinephrine (adrenaline) | Injection | 30 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
oxygen | Inhalation (medicine gas) | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 100 mg to 500 mg | |
diclofenac | Injection | 75mg/mL | |
ibuprofen | Oral liquid | 200 mg/5 mL | a |
ibuprofen | Tablet | 200 mg | |
ibuprofen | Tablet | 400 mg | |
ibuprofen | Tablet | 600 mg | |
naproxen | Tablet | 250 mg | |
naproxen | Tablet | 500 mg | |
naproxen | Tablet | 550 mg | |
paracetamol | Suppository | 100 mg | |
paracetamol | Tablet | 100 mg to 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
codeine | Tablet | 30 mg (phosphate) | |
morphine | Injection | 10 mg/ml | |
morphine | Oral liquid | 10 mg/5 ml | |
morphine | Tablet (controlled release) | 10 mg | |
morphine | Tablet (prolonged release) | 20 mg- 200 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amitriptyline | Tablet | 10 mg | |
amitriptyline | Tablet | 25 mg | |
amitriptyline | Tablet | 75 mg | |
cyclizine | Injection | 50 mg/ml | |
cyclizine | Tablet | 50 mg | |
dexamethasone | Injection | 4 mg/mL | |
dexamethasone | Oral liquid | 2 mg/5 mL | |
dexamethasone | Tablet | 2 mg | |
dexamethasone | Tablet | 4 mg | |
diazepam | Injection | 2 mg/5 mL | |
diazepam | Injection | 5 mg/mL | |
diazepam | Rectal solution | 10 mg | |
diazepam | Rectal solution | 2.5 mg | |
diazepam | Rectal solution | 5 mg | |
diazepam | Tablet | 10 mg | |
diazepam | Tablet | 2 mg | |
diazepam | Tablet | 5 mg | |
docusate sodium | Capsule | 100 mg | |
docusate sodium | Oral liquid | 50 mg/5 ml | |
fluoxetine | Tablet | 20 mg | a |
haloperidol | Injection | 5 mg/mL | |
haloperidol | Oral liquid | 2 mg/mL | |
haloperidol | Solid oral dosage form | 0.5 mg | |
haloperidol | Tablet | 2 mg | |
haloperidol | Tablet | 5 mg | |
hyoscine butylbromide | Injection | 20 mg/ml in 1-mL ampoule | |
hyoscine hydrobromide | Transdermal patches | 1 mg/72 hours | |
lactulose | Oral liquid | 3.1-3.7 g/5 ml | |
loperamide | Tablet | 2 mg | |
metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
metoclopramide | Oral liquid | 5 mg/5 mL | |
metoclopramide | Tablet | 10mg | |
midazolam | Injection | 1 mg/ml | |
midazolam | Injection | 5 mg/mL | |
midazolam | Oral liquid | 2 mg/ml | |
midazolam | Tablet | 15 mg | |
midazolam | Tablet | 7.5 mg | |
ondansetron | Injection | 2 mg/ml | |
ondansetron | Oral liquid | 4 mg base/5 ml | |
ondansetron | Tablet | 4 mg | |
ondansetron | Tablet | 8 mg | |
senna | Oral liquid | 7.5 mg/5 ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dexamethasone | Injection | 4 mg/mL | |
epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
loratadine | Oral liquid | 1mg/ml | |
loratadine | Tablet | 10 mg | |
prednisolone | Oral liquid | 5 mg/mL | |
prednisolone | Tablet | 25 mg | |
prednisolone | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
charcoal, activated | Powder | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Injection | 1 mg/ml | |
atropine | Oral liquid | 10% | |
atropine | Oral liquid | 20% | |
calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
methylthioninium chloride (methylene blue) | Injection | 10 mg/ml | |
N-Acetylcysteine | Injection | 200 mg/mL | |
naloxone | Injection | 0.4 mg/mL | |
protamine sulfate | Injection | 10 mg/mL | |
sodium nitrite | Injection | 30 mg/mL | |
sodium thiosulfate | Injection | 250 mg/mL |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
deferoxamine | Powder for injection | 500 mg | |
dimercaprol | Injection | 50 mg/ml | |
edetate calcium disodium | Solution for injection | 200 mg/ ml | |
fomepizole | Injection | 1 g/mL | |
fomepizole | Injection | 5 mg/mL | |
succimer | Solid oral dosage form | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbamazepine | Oral liquid | 100 mg/5 ml | |
carbamazepine | Tablet | 100 mg | |
carbamazepine | Tablet | 200 mg | |
diazepam | Injection | 10 mg/mL | |
diazepam | Tablet | 10 mg | |
diazepam | Tablet | 2 mg | |
diazepam | Tablet | 5 mg | |
ethosuximide | Oral liquid | 250 mg/5 ml | |
lamotrigine | Tablet | 100 mg | |
lamotrigine | Tablet | 200 mg | |
lamotrigine | Tablet | 25 mg | |
lamotrigine | Tablet | 50 mg | |
lamotrigine | Tablet (buffered chewable, dispersible) | 100 mg | |
lamotrigine | Tablet (buffered chewable, dispersible) | 2 mg | |
lamotrigine | Tablet (buffered chewable, dispersible) | 200 mg | |
lamotrigine | Tablet (buffered chewable, dispersible) | 25 mg | |
lamotrigine | Tablet (buffered chewable, dispersible) | 5 mg | |
lamotrigine | Tablet (buffered chewable, dispersible) | 50 mg | |
lorazepam | Injection | 2 mg/mL | |
lorazepam | Injection | 4 mg/ml | |
magnesium sulfate | Injection | 500 mg/mL in 10-mL ampoule | |
magnesium sulfate | Injection | 500 mg/mL in 2-mL ampoule | |
midazolam | Injection | 1 mg/ml | |
midazolam | Injection | 10 mg/ml | |
midazolam | Injection | 5 mg/mL | |
phenobarbital | Oral liquid | 15 mg/5 mL | |
phenobarbital | Tablet | 15 mg to 100 mg | |
phenytoin | Injection | 50 mg/mL | |
phenytoin | Tablet | 100 mg | |
phenytoin | Tablet | 25 mg | |
phenytoin | Tablet | 50 mg | |
valproic acid (sodium valproate) | Oral liquid | 200 mg/5 ml | |
valproic acid (sodium valproate) | Tablet | 100 mg | |
valproic acid (sodium valproate) | Tablet | 200 mg | |
valproic acid (sodium valproate) | Tablet | 500 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ethosuximide | Capsule | 250 mg | |
valproic acid (sodium valproate) | Injection | 100mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albendazole | Tablet | 400 mg | |
mebendazole | Tablet | 100 mg | |
mebendazole | Tablet | 500 mg | |
praziquantel | Syrup | 50 mg/mL | |
praziquantel | Tablet | 150 mg | |
praziquantel | Tablet | 600 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albendazole | Tablet | 400 mg | |
diethylcarbamazine | Tablet | 100 mg (dihydrogen citrate) | |
diethylcarbamazine | Tablet | 50 mg (dihydrogen citrate) | |
ivermectin | Tablet | 3 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amoxicillin | Suspension | 125 mg/ 5 ml | |
amoxicillin | Suspension | 250 mg/5ml | |
amoxicillin | Tablet | 250 mg | |
amoxicillin | Tablet | 500 mg | |
amoxicillin + clavulanic acid | Oral liquid | 125 mg amoxicillin + 31.25 mg clavulanic acid/5 ml | |
amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
benzathine benzylpenicillin | Powder for injection | 1.44 g benzylpenicillin (= 2.4 million IU) in 5-ml vial | |
benzathine benzylpenicillin | Powder for injection | 900 mg benzylpenicillin (= 1.2 million IU) in 5-ml vial | |
benzylpenicillin | Powder for injection | 3 g (= 5 million IU) (sodium or potassium salt) in vial | |
benzylpenicillin | Powder for injection | 600 mg (= 1 million IU) (sodium or potassium salt) in vial | |
cefalexin | Oral liquid | 125 mg/5 mL | |
cefalexin | Oral liquid | 250 mg/5 mL | |
cefalexin | Tablet | 250 mg | |
cefazolin | Powder for injection | 1 g (as sodium salt) in vial | |
cefixime | Capsule | 400 mg (as trihydrate) | |
cefotaxime | Powder for injection | 250 mg | |
ceftazidime | Injection | 1 g | |
ceftazidime | Injection | 500 mg | |
ceftriaxone | Injection | 250 mg to 1000 g | |
cloxacillin | Capsule | 1 g (as sodium salt) | |
cloxacillin | Capsule | 500 mg | |
cloxacillin | Powder for injection | 500 mg (sodium salt) | |
flucloxacillin | Oral liquid | 125 mg/5 mL (sodium salt) | |
phenoxymethylpenicillin | Powder for oral liquid | 250 mg (as potassium salt)/5 ml | |
phenoxymethylpenicillin | Tablet | 250 mg (as potassium salt) | |
piperacillin sodium + tazobactum sodium | Injection | 2 g (as sodium) + 250 mg (as sodium) in vial | |
piperacillin sodium + tazobactum sodium | Solution for injection | 4 g/ 500 mg | |
procaine benzylpenicillin | Powder for injection | 1 g (=1 million IU) in vial | |
procaine benzylpenicillin | Powder for injection | 3 g (=3 million IU) in vial |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cefepime | Injection | 1 g in vial | |
cefepime | Solution for injection | 500 mg | |
ceftaroline | Injection | 400 mg- 600 mg | |
meropenem | Injection | 1g | |
meropenem | Injection | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
azithromycin | Oral liquid | 200 mg/5 mL | |
azithromycin | Tablet | 250 mg | |
azithromycin | Tablet | 500 mg | |
ciprofloxacin | Oral liquid | 125 mg/5 mL | |
ciprofloxacin | Oral liquid | 250 mg/5 ml (anhydrous) | |
ciprofloxacin | Tablet | 250 mg | |
ciprofloxacin | Tablet | 500 mg | |
clarithromycin | Suspension | 125 mg/5 ml | |
clarithromycin | Suspension | 250 mg/5 ml | |
clarithromycin | Tablet | 500 mg | |
clindamycin | Capsule | 150 mg | |
clindamycin | Injection | 150 mg/mL | |
clindamycin | Suspension | 75 mg/5mL | |
doxycycline | Capsule | 100 mg | a |
doxycycline | Oral liquid | 25 mg/5 ml (anhydrous) | a |
doxycycline | Oral liquid | 50 mg/5 ml (anhydrous) | a |
erythromycin | Oral liquid | 125 mg (estolate)/5 mL | |
erythromycin | Tablet | 250 mg | |
erythromycin | Tablet | 500 mg | |
gentamicin | Injection | 10 to 40mg/ml | |
metronidazole | Injection | 500 mg in 100-mL vial | |
metronidazole | Suspension | 200 mg/ 5 ml | |
metronidazole | Tablet | 200 mg to 500 mg | |
nitrofurantoin | Oral liquid | 25 mg/5 ml | |
nitrofurantoin | Tablet | 100 mg | |
sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 10-mL ampoule | |
sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 5-mL ampoule | |
sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
sulfamethoxazole + trimethoprim | Tablet | 100 mg + 20 mg | |
sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg | |
tetracycline | Solid oral dosage form | 250 mg | |
trimethoprim | Tablet | 100 mg | |
trimethoprim | Tablet | 200 mg | |
vancomycin | Injection | 250 mg | |
vancomycin | Injection | 500 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ciprofloxacin | Injection | 2mg (lactate)/ml | |
levofloxacin | Tablet | 500 mg | |
linezolid | injection for intravenous administration | 2 mg/ ml | |
linezolid | Powder for oral liquid | 100 mg/ 5 ml | |
linezolid | Tablet | 400 mg | |
linezolid | Tablet | 600 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clofazimine | Capsule | 100 mg | |
clofazimine | Capsule | 50 mg | |
dapsone | Tablet | 100 mg | |
dapsone | Tablet | 25 mg | |
dapsone | Tablet | 50 mg | |
rifampicin | Solid oral dosage form | 150 mg | |
rifampicin | Solid oral dosage form | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ethambutol | Oral liquid | 25 mg/ml | |
ethambutol | Tablet | 100 mg | |
ethambutol | Tablet | 400mg | |
ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
ethambutol + isoniazid + rifampicin | Tablet | 275 mg + 75 mg + 150 mg | |
isoniazid | Oral liquid | 50 mg/5 ml | |
isoniazid | Tablet | 300 mg | |
isoniazid | Tablet (scored) | 50 mg | |
isoniazid + pyrazinamide + rifampicin | Tablet | 30 mg/ 150 mg/ 60mg | |
isoniazid + pyrazinamide + rifampicin | Tablet | 75 mg + 400 mg + 150 mg | |
isoniazid + rifampicin | Tablet | 150 mg + 150 mg | |
isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
isoniazid + rifampicin | Tablet | 60 mg + 60 mg | |
isoniazid + rifampicin | Tablet | 75 mg + 150 mg | |
isoniazid + rifampicin | Tablet (dispersible) | 50 mg + 75 mg | |
pyrazinamide | Tablet | 400 mg | |
pyrazinamide | Tablet (dispersible) | 150 mg | |
pyrazinamide | Tablet (dispersible) | 150 mg | |
rifabutin | Capsule | 150 mg | |
rifampicin | Oral liquid | 20 mg/ml | |
rifampicin | Solid oral dosage form | 300 mg | |
rifampicin | Tablet | 150 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amikacin | Powder for injection | 1 g (as sulfate) in vial | |
amikacin | Powder for injection | 100 mg (as sulfate) in vial | |
amikacin | Powder for injection | 500 mg (as sulfate) in vial | |
capreomycin | Powder for injection | 1 g (as sulfate) in vial | |
cycloserine | Solid oral dosage form | 125 mg | |
cycloserine | Solid oral dosage form | 250 mg | |
ethionamide | Tablet | 125 mg | |
ethionamide | Tablet | 250 mg | |
kanamycin | Powder for injection | 1g | |
levofloxacin | Tablet | 250 mg | |
levofloxacin | Tablet | 500 mg | |
levofloxacin | Tablet | 750 mg | |
moxifloxacin | Tablet | 400 mg | |
p-aminosalicylic acid | Granules | 4 g in sachet | |
streptomycin | Powder for injection | 1 g |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clotrimazole | Cream | 1% | |
clotrimazole | Cream | 10% | |
clotrimazole | Vaginal tablet | 100 mg | |
clotrimazole | Vaginal tablet | 500 mg | |
fluconazole | Injection | 2 mg/mL in vial | |
fluconazole | Oral liquid | 50 mg/5 mL | |
fluconazole | Tablet | 150 mg | |
fluconazole | Tablet | 50 mg | |
griseofulvin | Suspension | 125 mg/ 5 ml | |
griseofulvin | Tablet | 125 mg | |
griseofulvin | Tablet | 250 mg | |
griseofulvin | Tablet | 500mg | |
nystatin | Oral liquid | 100 000 IU/ml | |
nystatin | Oral liquid | 50 mg/5 ml | |
nystatin | Pessary | 100 000 IU | |
nystatin | Tablet | 100 000 IU | |
nystatin | Tablet | 500 000 IU |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amphotericin B | Injection | 50 mg | |
flucytosine | Capsule | 250 mg | |
flucytosine | Infusion | 2.5 g in 250 ml | |
itraconazole | Capsule | 100 mg | |
itraconazole | Oral solution | 10 mg/ ml | |
voriconazol | Powder for injection | 200 mg in vial | |
voriconazol | Powder for oral liquid | 40 mg/ ml | |
voriconazol | Tablet | 200 mg | |
voriconazol | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
abacavir | Tablet | 300 mg | |
abacavir (ABC) | Oral liquid | 20mg/ml | |
emtricitabine (FTC) | Capsule | 200 mg | |
lamivudine (3TC) | Oral liquid | 50 mg/5 ml | |
lamivudine (3TC) | Tablet | 150 mg | |
tenofovir disoproxil fumarate | Tablet | 300 mg | |
zidovudine (ZDV or AZT) | Capsule | 100 mg | |
zidovudine (ZDV or AZT) | Oral liquid | 50 mg/5 mL | |
zidovudine (ZDV or AZT) | Tablet | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
efavirenz (EFV or EFZ) | Capsule | 600 mg | |
efavirenz (EFV or EFZ) | Oral liquid | 150 mg/5 ml | |
efavirenz (EFV or EFZ) | Tablet | 100 mg | |
efavirenz (EFV or EFZ) | Tablet | 50 mg | |
efavirenz (EFV or EFZ) | Tablet (scored) | 200 mg | |
etravirine | Tablet | 100 mg | |
etravirine | Tablet | 200 mg | |
nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
nevirapine (NVP) | Tablet | 200 mg | |
nevirapine (NVP) | Tablet | 50 mg | |
nevirapine (NVP) | Tablet (dispersible) | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atazanavir + ritonavir | Tablet | 300 mg + 100 mg | |
darunavir | Tablet | 400 mg | |
darunavir | Tablet | 600 mg | |
darunavir | Tablet | 75 mg | |
darunavir | Tablet | 800 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
lopinavir + ritonavir (LPV/r) | Solid oral dosage form | 40 mg + 10 mg | |
lopinavir + ritonavir (LPV/r) | Tablet | 100 mg/ 25 mg | |
lopinavir + ritonavir (LPV/r) | Tablet | 200 mg/ 50 mg | |
ritonavir | Oral liquid | 400 mg/5 ml | |
ritonavir | Tablet | 100 mg | |
ritonavir | Tablet | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dolutegravir | Tablet | 50 mg | |
raltegavir | Tablet | 400 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
abacavir + lamivudine | Tablet | 120 mg/ 60 mg | |
abacavir + lamivudine | Tablet | 600 mg/ 300 mg | |
abacavir + lamivudine | Tablet | 600mg + 300mg | |
dolutegravir + lamivudina + tenofovir | Tablet | 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil) | |
efavirenz + emtricitabine + tenofovir | Tablet | 600 mg + 200 mg + 300 mg | |
emtricitabine + tenofovir | Tablet | 200 mg + 300 mg | |
lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
lamivudine + nevirapine + zidovudine | Tablet | 30 mg + 50 mg + 60 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
lamivudine + zidovudine | Tablet (dispersible, scored) | 30 mg + 60 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ganciclovir | Powder for injection | 500 mg | |
ribavirin | injection for intravenous administration | 1 g in 10-ml phosphate buffer solution | |
ribavirin | injection for intravenous administration | 800 mg in 10-ml phosphate buffer solution | |
ribavirin | Solid oral dosage form | 200 mg | |
ribavirin | Solid oral dosage form | 400 mg | |
ribavirin | Solid oral dosage form | 600 mg | |
valgancyclovir | Tablet | 450mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
entecavir | Oral liquid | 0.05 mg/ ml | |
entecavir | Tablet | 0.5 mg | |
entecavir | Tablet | 1 mg | |
tenofovir disoproxil fumarate | Tablet | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ribavirin | injection for intravenous administration | 1 g in 10-ml phosphate buffer solution | |
ribavirin | injection for intravenous administration | 800 mg in 10-ml phosphate buffer solution | |
ribavirin | Solid oral dosage form | 200 mg | |
ribavirin | Solid oral dosage form | 400 mg | |
ribavirin | Solid oral dosage form | 600 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
daclatasvir | Capsule | 30 mg | |
daclatasvir | Capsule | 60 mg | |
interferon alpha | Injection | Pegylated interferon alfa (2a or 2b) 100 mg | |
interferon alpha | Injection | Pegylated interferon alfa (2a or 2b) 180 mg | |
interferon alpha | Injection | Pegylated interferon alfa (2a or 2b) 80 mg | |
ledipasvir + sofosbuvir | Tablet | 90 mg/ 400 mg | |
sofosbuvir | Tablet | 400 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
metronidazole | Injection | 500 mg in 100-mL vial | |
metronidazole | Suspension | 125 mg/5 mL | |
metronidazole | Suspension | 250 mg/5 mL | |
metronidazole | Tablet | 200 mg to 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
artemether + lumefantrine | Tablet | 20 mg + 120 mg | a |
artesunate + mefloquine | Tablet | 100 mg + 220 mg | |
artesunate + mefloquine | Tablet | 25mg; 55mg | |
chloroquine | Oral liquid | 50 mg (as phosphate or sulfate)/5 ml | |
chloroquine | Tablet | 150 mg | |
clindamycin | Capsule | 150 mg | |
doxycycline | Tablet | 100mg | |
primaquine | Tablet | 15 mg | |
primaquine | Tablet | 7.5 mg | |
quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chloroquine | Oral liquid | 50 mg (as phosphate or sulfate)/5 ml | |
chloroquine | Tablet | 150 mg | |
clindamycin | Capsule | 150 mg | |
doxycycline | Tablet | 100mg | |
mefloquine | Tablet | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
pyrimethamine | Tablet | 25 mg | |
sulfamethoxazole + trimethoprim | Solution for injection | 80 mg/ml / 16 mg/ ml | |
sulfamethoxazole + trimethoprim | Tablet | 100 mg + 20 mg | |
sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 300 mg to 500 mg | |
paracetamol | Oral liquid | 120 mg/5 mL | |
paracetamol | Oral liquid | 125 mg/5 ml | |
paracetamol | Tablet | 300 mg to 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
propranolol | Tablet | 20 mg | |
propranolol | Tablet | 40mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
trastuzumab | Injection | 60 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
all trans retinoid acid (ATRA) | Capsule | 10 mg | |
allopurinol | Tablet | 100 mg | |
allopurinol | Tablet | 300 mg | |
asparaginase | Injection | 10000 UI | |
bendamustine | Injection | 180 mg/2 mL | |
bendamustine | Injection | 45 mg/0.5 mL | |
bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
calcium folinate | Injection | 3 mg/mL in 10-mL ampoule | |
calcium folinate | Tablet | 15 mg | |
capecitabine | Tablet | 150 mg | |
capecitabine | Tablet | 500 mg | |
carboplatin | Injection | 150 mg/15 mL | |
carboplatin | Injection | 450 mg/45 mL | |
carboplatin | Injection | 50 mg/5 mL | |
carboplatin | Injection | 600 mg/60 mL | |
chlorambucil | Tablet | 2 mg | |
cisplatin | Injection | 100 mg/100 mL | |
cisplatin | Injection | 50 mg/ 50 ml | |
cyclophosphamide | Tablet | 25 mg | |
cytarabine | Powder for injection | 100 mg in vial | |
cytarabine | Powder for injection | 50 mg | |
dacarbazine | Powder for injection | 100 mg in vial | |
dactinomycin | Powder for injection | 500 mcg in vial | |
daunorubicin | Injection | 50 mg | |
docetaxel | Injection | 20 mg/ml | |
docetaxel | Injection | 40 mg/mL | |
doxorubicin | Powder for injection | 10 mg (hydrochloride) in vial | |
doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
etoposide | Capsule | 100 mg | |
etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
filgrastim | Injection | 120 micrograms/0.2 mL in pre-filled syringe. | |
filgrastim | Injection | 300 micrograms/0.5 mL in pre-filled syringe. | |
filgrastim | Injection | 300 micrograms/mL in 1 mL vial | |
filgrastim | Injection | 480 micrograms/0.8 mL in pre-filled syringe | |
filgrastim | Injection | 480 micrograms/1.6 mL in 1.6 mL vial | |
fludarabine | Injection | 50 mg (phosphate) | |
fludarabine | Tablet | 10 mg | |
fluorouracil | Injection | 50 mg/5 mL | |
gemcitabine | Injection | 1g | |
gemcitabine | Injection | 200mg | |
hydroxycarbamide | Solid oral dosage form | 1 g | |
hydroxycarbamide | Solid oral dosage form | 200 mg | |
hydroxycarbamide | Solid oral dosage form | 250 mg | |
hydroxycarbamide | Solid oral dosage form | 300 mg | |
hydroxycarbamide | Solid oral dosage form | 400 mg | |
hydroxycarbamide | Solid oral dosage form | 500 mg | |
ifosfamide | Powder for injection | 1 g in vial | |
ifosfamide | Powder for injection | 2 g in vial | |
ifosfamide | Powder for injection | 500 mg vial | |
imatinib | Tablet | 100 mg (as mesylate) | |
imatinib | Tablet | 400 mg (as mesylate) | |
irinotecan | Injection | 100 mg/ 5 ml in 5 ml vial | |
irinotecan | Injection | 40 mg/ 2 ml in 2 ml vial | |
irinotecan | Injection | 500 mg/ 25 ml in 25 ml vial | |
melphalan | Injection | 50 mg/mL | |
melphalan | Tablet | 2 mg | |
mercaptopurine | Tablet | 50 mg | |
mesna | Injection | 100 mg/ml in 10-ml ampoules | |
mesna | Injection | 100 mg/ml in 4-ml ampoules | |
mesna | Tablet | 400 mg | |
mesna | Tablet | 600 mg | |
methotrexate | Injection | 2.5 mg/mL | |
methotrexate | Tablet | 2.5 mg | |
oxaliplatin | Injection | 100 mg | |
oxaliplatin | Injection | 100 mg/ 20 ml in 20 ml vial | |
oxaliplatin | Injection | 200 mg/ 40 ml in 40 ml vial | |
oxaliplatin | Injection | 50 mg | |
oxaliplatin | Injection | 50 mg/ 10 ml in 10 ml vial | |
paclitaxel | Powder for injection | 6 mg/ml | |
procarbazine | Capsule | 50 mg | |
rituximab | Injection | 10 mg/mL in 10-mL vial | |
rituximab | Injection | 500 mg/50 mL | |
thalidomide | Tablet | 100 mg | |
thalidomide | Tablet | 50 mg | |
trastuzumab | Injection | 150 mg | |
trastuzumab | Injection | 440 mg | |
vinblastine | Injection | 10 mg | |
vincristine | Injection | 1 mg/mL | |
vincristine | Injection | 5 mg/mL | |
vinorelbine | Injection | 10 mg/mL | |
vinorelbine | Injection | 50 mg | |
zoledronic acid | Concentrate for solution for infusion | 4 mg/ 5 ml in 5 ml vial | |
zoledronic acid | Solution for IV infusion | 4 mg/ 100 ml in 100 ml bottle |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anastrozole | Tablet | 1mg | |
bicalutamide | Tablet | 50 mg | |
dexamethasone | Injection | 30 mg/mL | |
dexamethasone | Oral liquid | 2 mg/5 mL | |
hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
leuprorelin | Injection | 1 mg/0.2 ml in vial 2.8ml | |
methylprednisolone | Injection | 40 mg/ml | |
methylprednisolone | Injection | 80 mg (acetate)/mL | |
prednisolone | Tablet | 25 mg | |
prednisolone | Tablet | 5 mg | |
tamoxifen | Tablet | 10 mg (as citrate) | |
tamoxifen | Tablet | 20 mg (as citrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
biperiden | Injection | (lactate) 5 mg/mL | |
biperiden | Tablet | (lactate) 2 mg | |
levodopa + carbidopa | Capsule | 250mg + 25mg | |
levodopa + carbidopa | Tablet | 100 mg + 10 mg | |
levodopa + carbidopa | Tablet | 250 mg + 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ferrous fumarate + folic acid | Tablet | 60 mg + 400 mcg | |
ferrous sulfate | Oral solution | 25 mg/ ml | |
folic acid | Syrup | 1 mg | |
folic acid | Syrup | 5 mg | |
folic acid | Tablet | 0.4 mg | |
folic acid | Tablet | 1 mg | |
folic acid | Tablet | 5 mg | |
hydroxocobalamin | Injection | 1 mg/mL |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
erythropoiesis - stimulating agents | injection: pre- filled syringe | 1000 IU/ 0.5 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 10000 IU/1 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 20 000 IU/ 0.5 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 2000 IU/ 0.5 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 3000 IU/ 0.3 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 40 000 IU/ 1 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 4000 IU/ 0.4 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 5000 IU/ 0.5 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 6000 IU/ 0.6 mL | |
erythropoiesis - stimulating agents | injection: pre- filled syringe | 8000 IU/ 0.8 mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
enoxaparin | Injection | 100 mg/ 1 mL | |
enoxaparin | Injection | 120 mg/ 0.8 mL | |
enoxaparin | Injection | 150 mg/ 1 mL | |
enoxaparin | Injection | 20 mg/ 0.2ml | |
enoxaparin | Injection | 40 mg/ 0.4 ml | |
enoxaparin | Injection | 60 mg/ 0.6 ml | |
enoxaparin | Injection | 80 mg/0.8 ml | |
heparin sodium | Injection | 1000 U/ml | |
heparin sodium | Injection | 20000 U/ml | |
heparin sodium | Injection | 5000 U/ml | |
phytomenadione | Injection | 1 mg/ ml | |
phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
phytomenadione | Tablet | 10 mg | |
protamine sulfate | Injection | 10 mg/mL | |
tranexamic acid | Injection | 100 mg/ml | |
warfarin | Tablet | 1 mg (sodium salt) | |
warfarin | Tablet | 2 mg (sodium salt) | |
warfarin | Tablet | 5 mg (sodium salt) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
deferoxamine | Powder for injection | 500 mg | |
hydroxycarbamide | Solid oral dosage form | 1 g | |
hydroxycarbamide | Solid oral dosage form | 200 mg | |
hydroxycarbamide | Solid oral dosage form | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dextran 70 | Parenteral solution | 6% | |
fresh - frozen plasma | N/A | N/A | |
platelets | N/A | N/A | |
red blood cells | N/A | N/A | |
whole blood | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anti-D immunoglobulin (human) | Injection | 250 mcg in single-dose vial | |
rabies immunoglobulin | Injection | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
factor VIII | Solution for injection | 500 UI |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atenolol | Tablet | 100 mg | |
atenolol | Tablet | 50 mg | |
bisoprolol | Tablet | 1.25 mg | |
bisoprolol | Tablet | 5 mg | |
glyceryl trinitrate | Tablet (sublingual) | 500 mcg | |
isosorbide dinitrate | Tablet (sublingual) | 5 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carvedilol | Tablet | 12.5 mg | |
carvedilol | Tablet | 25 mg | |
carvedilol | Tablet | 3.125 mg | |
carvedilol | Tablet | 6.25 mg | |
metoprolol | Tablet | 100 mg | |
metoprolol | Tablet | 25 mg | |
metoprolol | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atenolol | Tablet | 100 mg | |
atenolol | Tablet | 50 mg | |
digoxin | Injection | 0.5 mg in 2 mL ampoule | |
digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
digoxin | Oral liquid | 50 micrograms/mL | |
digoxin | Tablet | 250 mcg | |
digoxin | Tablet | 62.5 micrograms | |
epinephrine (adrenaline) | Injection | 100 mcg/mL | |
lidocaine | Injection | 20 mg (hydrochloride)/ml in 5-ml ampoule | |
verapamil | Injection | 2.5 mg/mL | |
verapamil | Tablet | 40 mg | |
verapamil | Tablet | 80 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amiodarone | Injection | 50 mg/ml | |
amiodarone | Tablet | 100 mg | |
amiodarone | Tablet | 200 mg | |
amiodarone | Tablet (HCI) | 400 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amlodipine | Tablet | 5 mg | |
atenolol | Tablet | 100 mg | |
atenolol | Tablet | 50 mg | |
bisoprolol | Tablet | 100 mg | |
bisoprolol | Tablet | 50 mg | |
chlorthalidone | Tablet | 12.5 mg | |
chlorthalidone | Tablet | 25 mg | |
enalapril | Tablet | 2.5 mg | |
enalapril | Tablet | 5 mg | |
enalapril | Tablet | 5 mg | |
hydralazine | Injection | 25 mg/mL | |
hydralazine | Tablet | 25 mg | |
hydralazine | Tablet | 50 mg | |
hydrochlorothiazide | Tablet | 12.5 mg | |
hydrochlorothiazide | Tablet | 25 mg | |
losartan | Tablet | 100 mg | |
losartan | Tablet | 25 mg | |
losartan | Tablet | 50mg | |
methyldopa | Tablet | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atenolol | Tablet | 100 mg | |
atenolol | Tablet | 50 mg | |
bisoprolol | Tablet | 100 mg | |
bisoprolol | Tablet | 50 mg | |
digoxin | Tablet | 250 mcg | |
enalapril | Tablet | 2.5 mg | |
enalapril | Tablet | 5 mg | |
furosemide | Injection | 10 mg/ml | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Tablet | 25 mg | |
losartan | Tablet | 100 mg | |
losartan | Tablet | 25 mg | |
losartan | Tablet | 50mg | |
spironolactone | Tablet | 25 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 100 mg | |
clopidogrel | Tablet | 300 mg | |
clopidogrel | Tablet | 75 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
streptokinase | Powder for injection | 1.5 million IU in vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
simvastatin | Tablet | 10 mg | |
simvastatin | Tablet | 20 mg | |
simvastatin | Tablet | 40 mg | |
simvastatin | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
miconazole | Cream | 2% (nitrate) | |
selenium sulfide | Suspension | 2% | |
terbinafine | Cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
mupirocin | Ointment | 2% | |
potassium permanganate | Aqueous solution | 1:10 000 | |
silver sulfadiazine | Cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
betamethasone | Topical forms | 1% | |
calamine | Lotion | 8% | |
hydrocortisone | Cream | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benzoyl peroxide | Cream | 5% | |
fluorouracil | Ointment | 5% | |
podophyllin | Solution | 10% to 25% | |
salicylic acid | Solution | 5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benzyl benzoate | Lotion | 25% | |
permethrin | Cream | 5% | |
permethrin | Lotion | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
fluorescein | Solution (eye drops) | 1% | |
tropicamide | Solution (eye drops) | 0.5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amidotrizoate | Injection | 140 mg/mL | |
amidotrizoate | Injection | 420 mg/mL | |
barium sulfate | Suspension | 150 mg in 500mLs | |
iohexol | Injection | 140 mg- 350 mg iodine/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
alcohol based hand rub | Solution | containing ethanol 80% volume/volume | |
chlorhexidine | Solution | 5% | |
chlorhexidine | Solution | 7% | |
ethanol | Solution | 70% (denatured) | |
iodine-povidone | Solution | 10% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorine base compound | Powder | (0.1% available chlorine) for solution | |
glutaraldehyde | Solution | 2% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
furosemide | Injection | 10 mg/ml | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Tablet | 25 mg | |
mannitol | Injectable solution | 10% | |
mannitol | Injectable solution | 20% | |
spironolactone | Oral liquid | 10 mg/5 ml | |
spironolactone | Oral liquid | 25 mg/5 ml | |
spironolactone | Oral liquid | 5 mg/5 ml | |
spironolactone | Tablet | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
esomeprazole | Capsule | 40 mg | |
omeprazole | Capsule | 20 mg | |
omeprazole | Injection | 40 mg | |
ranitidine | Injection | 25 mg/ml (hydrochloride) | |
ranitidine | Syrup | 75 mg/ 5 ml | |
ranitidine | Tablet | 150 mg | |
ranitidine | Tablet | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dexamethasone | Injection | 4 mg/mL | |
dexamethasone | Oral liquid | 0.5 mg/5 mL | |
dexamethasone | Oral liquid | 2 mg/5 mL | |
dexamethasone | Solid oral dosage form | 0.5 mg | |
dexamethasone | Solid oral dosage form | 0.75 mg | |
dexamethasone | Solid oral dosage form | 1.5 mg | |
dexamethasone | Solid oral dosage form | 4 mg | |
metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
metoclopramide | Oral liquid | 5 mg/5 mL | |
metoclopramide | Tablet | 10mg | |
ondansetron | Injection | 2 mg/ml | |
ondansetron | Oral liquid | 4 mg base/5 ml | |
ondansetron | Solid oral dosage form | Eq 24 mg base | |
ondansetron | Solid oral dosage form | Eq 4 mg base | |
ondansetron | Solid oral dosage form | Eq 8 mg base |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
sulfasalazine | Suppository | 500 mg | |
sulfasalazine | Tablet | 500 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
hydrocortisone | Suppository | 25 mg (acetate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
senna | Tablet | 7.5 mg (sennosides) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
oral rehydration salts | Powder for dilution | 1 L | |
oral rehydration salts | Powder for dilution | 200 ml | |
oral rehydration salts | Powder for dilution | 500 ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
zinc | Tablet | 20mg | |
zinc sulfate | Oral liquid | 10mg | |
zinc sulfate | Oral liquid | 20 mg | |
zinc sulfate | Tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
hydrocortisone | Tablet | 10 mg | |
hydrocortisone | Tablet | 20 mg | |
hydrocortisone | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
testosterone | Injection | 200 mg (enanthate) in 1-mL ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
levonorgestrel | Tablet | 30 micrograms | |
levonorgestrel | Tablet | 750 micrograms (pack of two) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
estradiol cypionate + medroxyprogesterone acetate | Injection | 5 mg + 25 mg | |
medroxyprogesterone | Injection | 150 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
copper-containing device | N/A | T 380 mm2 |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
condoms | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
levonorgestrel-releasing implant | N/A | Two-rod levonorgestrel-releasing implant, each rod containing 75 mg of levonorgestrel (150 mg total) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glibenclamide | Tablet | 2.5 mg | |
glibenclamide | Tablet | 5 mg | |
gliclazide | Solid oral dosage form | 30 mg | |
gliclazide | Solid oral dosage form | 60 mg | |
gliclazide | Solid oral dosage form | 80 mg | |
glucagon | Injection | 1 mg/mL | |
Insulin | Injection | (short acting) 100U/mL in 10 mL | |
intermediate-acting insulin | Injection | 40 IU/ml in 10-ml vial | |
metformin | Tablet | 500 mg | |
NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clomifene | Tablet | 50 mg (citrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
levothyroxine | Tablet | 100 mcg (sodium salt) | |
levothyroxine | Tablet | 25 mcg (sodium salt) | |
levothyroxine | Tablet | 50 mcg (sodium salt) |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
Lugol's solution | Oral liquid | about 130 mg total iodine/ml | |
potassium iodide | Tablet | 60 mg | |
propylthiouracil | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
tuberculin, purified protein derivative (PPD) | Injection | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anti rabies human serum | Solution for injection | 150 UI/ ml | |
diphtheria antitoxin | Injection | 10 000 IU in vial | |
diphtheria antitoxin | Injection | 20 000 IU in vial | |
tetanus antitoxin | Injection | 1500 IU/ 1.5 ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
BCG vaccine | Injection | N/A | |
cholera vaccine | N/A | N/A | |
diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
hepatitis A vaccine | N/A | N/A | |
hepatitis B vaccine | Injection | N/A | |
human papilloma virus (HPV) vaccine | N/A | N/A | |
meningococcal meningitis vaccine | N/A | N/A | |
MR vaccine | Injection | measles, rubella | |
mumps vaccine | N/A | N/A | |
pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) | |
poliomyelitis vaccine | Injection | N/A | |
rabies vaccine | N/A | N/A | |
tetanus vaccine | Injection | N/A | |
typhoid vaccine | N/A | N/A | |
varicella vaccine | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atracurium | Injection | 10 mg/mL (besylate) | |
neostigmine | Injection | 2.5 mg (metilsulfate) in 1-ml ampoule | |
neostigmine | Injection | 500 mcg (methylsulfate) in 1-mL ampoule | |
neostigmine | Tablet | 15 mg (bromide) | |
succinylcholine chloride | Injection | 50 mg/ ml x 2 ml | |
vecuronium | Powder for injection | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aciclovir | Eye ointment | 3% | |
ciprofloxacin | Solution (eye drops) | 0.3% | |
erythromycin | Eye ointment | 0.5% | |
gentamicin | Solution (eye drops) | 0.3% | |
tetracycline | Eye ointment | 1% (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
prednisolone | Solution (eye drops) | 0.5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
tetracaine | Solution (eye drops) | 0.5% (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetazolamide | Tablet | 250 mg | |
latanoprost | Solution (eye drops) | 0.005% | |
pilocarpine | Solution (eye drops) | 2% (hydrochloride) | |
pilocarpine | Solution (eye drops) | 4% (hydrochloride or nitrate) | |
timolol | Solution (eye drops) | 0.25% (maleate) | |
timolol | Solution (eye drops) | 0.5 % |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
epinephrine (adrenaline) | Solution (eye drops) | 2% (as hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bevacizumab | Infusion | 25mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ergometrine | Injection | 0,2 mg/ml | |
oxytocin | Injection | 10 units/ml |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
misoprostol | Tablet | 200 mcg | |
misoprostol | Vaginal tablet | 25 mcg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
nifedipine | Immediate-release capsule | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
intraperitoneal dialysis solution (of appropriate composition) | Parenteral solution | N/A | |
sodium chloride | N/A | 0.9% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
fluphenazine | Injection | 25 mg (decanoate or enantate) in 1-mL ampoule | |
risperidone | Solid oral dosage form | 0.5 mg to 6 mg |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorpromazine | Injection | 25 mg/ ml | |
chlorpromazine | Oral liquid | 25 mg (hydrochloride)/5 mL | |
chlorpromazine | Tablet | 100 mg | |
clozapine | Solid oral dosage form | 25 to 200 mg | |
haloperidol | Injection | 5 mg/mL | |
haloperidol | Oral liquid | 2 mg/mL | |
haloperidol | Tablet | 0.5 mg | |
haloperidol | Tablet | 2 mg | |
haloperidol | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amitriptyline | Tablet | 25 mg | |
amitriptyline | Tablet | 75 mg | |
fluoxetine | Solid oral dosage form | 20mg | a |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbamazepine | Tablet | 100 mg | |
carbamazepine | Tablet | 200 mg | |
divalproex sodium | Tablet | 500 mg | |
lithium carbonate | Tablet | 300 mg | |
valproic acid (sodium valproate) | Tablet | 200 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clomipramine | Solid oral dosage form | 10 mg | |
clomipramine | Solid oral dosage form | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
nicotine replacement therapy (NRT) | Chewing gum | 2 mg (as polacrilex) | |
nicotine replacement therapy (NRT) | Chewing gum | 4 mg (as polacrilex) | |
nicotine replacement therapy (NRT) | Transdermal patches | 5 mg to 30 mg/16 hrs | |
nicotine replacement therapy (NRT) | Transdermal patches | 7 mg to 21 mg/24 hrs |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
beclometasone | Inhalation (aerosol) | 100 micrograms (dipropionate) per dose (as CFC free forms) | |
beclometasone | Inhalation (aerosol) | 50 mcg (dipropionate) per dose (as CFC free forms) | |
budesonide | Inhalation (aerosol) | 100 micrograms per dose | |
budesonide | Inhalation (aerosol) | 200 micrograms per dose | |
budesonide + formoterol | turbohaler | 6/100 mcg | |
budesonide + formoterol | turbohaler | 6/200 mcg | |
epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
ipratropium bromide | Solution for inhalation | 20 mcg/ dose | |
salbutamol | Injection | 50 mcg (as sulfate)/mL in 5-mL ampoule | |
salbutamol | Solution for inhalation | 5 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
oral rehydration salts | Powder for dilution | 1 L | |
oral rehydration salts | Powder for dilution | 200 ml | |
oral rehydration salts | Powder for dilution | 500 ml | |
potassium chloride | Powder for solution | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glucose | Injectable solution | 5% (isotonic) | |
glucose | Injectable solution | 50% (hypertonic) | |
glucose | Parenteral formulation | 10% | |
glucose with sodium chloride | Injectable solution | 5% glucose, 0.45% sodium chloride (equivalent to 75 mmol/L Na+ and 75 mmol/L Cl-) | |
glucose with sodium chloride | Injectable solution | 5% glucose, 0.9% sodium chloride (equivalent to 150 mmol/L Na+ and 150 mmol/L Cl-) | |
potassium chloride | Injection | 11.2%, 20 mL | |
potassium chloride | Solution for dilution | 7.5% (equivalent to K 1 mmol/ml and Cl 1 mmol/ml) | |
ringer lactate solution | Parenteral formulation | N/A | |
sodium bicarbonate | Injection | 8.4% | |
sodium bicarbonate | Solution for IV infusion injection | 1.4% | |
sodium chloride | N/A | 0.9% | |
sodium chloride | Parenteral formulation | 0.45% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
water for injection | N/A | 10-ml ampoules | |
water for injection | N/A | 2-ml ampoules | |
water for injection | N/A | 5-mL ampoules |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ascorbic acid | Tablet | 500 mg | |
calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
hydroxocobalamin | Injection | 1 mg/mL | |
pyridoxine | Tablet | 25 mg (hydrochloride) | |
riboflavin | Tablet | 5 mg | |
thiamine | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetic acid | Topical | 2%, in alcohol | |
budesonide | Nasal spray | 100 micrograms per dose | |
ciprofloxacin | ear drops | 0.3% | |
oxymethazoline | Nasal spray | 0.5 mg/ml | a |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
caffeine citrate | Injection | 20 mg/ml (equivalent to 10 mg caffeine base/ml) | |
caffeine citrate | Oral liquid | 20 mg/ml (equivalent to 10 mg caffeine base/ml) | |
chlorhexidine | Solution | 7.1% (digluconate) | |
gentian violet | Solution | N/A |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ibuprofen | Solution for injection | 5 mg/mL | |
prostaglandin E | Solution for injection | Prostaglandin E1: 0.5 mg/ml in alcohol | |
prostaglandin E | Solution for injection | Prostaglandin E2: 1 mg/ml | |
surfactant | Suspension for intratracheal instillation | 25 mg/ml | |
surfactant | Suspension for intratracheal instillation | 80 mg/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dexamethasone | Injection | 4 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
allopurinol | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chloroquine | Tablet | 100 mg (as phosphate or sulfate) | |
chloroquine | Tablet | 150 mg (as phosphate or sulfate) |
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
azathioprine | Tablet | 50 mg | |
hydroxychloroquine | Tablet | 200 mg | |
methotrexate | Tablet | 2.5 mg | |
penicillamine | Solid oral dosage form | 250 mg | |
sulfasalazine | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|
Complementary list
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Suppository | 50 mg to 150 mg | |
acetylsalicylic acid | Tablet | 100 mg | |
acetylsalicylic acid | Tablet | 500 mg |